{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:10:23Z","timestamp":1649182223527},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40264-013-0088-9","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T10:06:19Z","timestamp":1374228379000},"page":"989-993","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Hypotension with Co-prescription of Macrolide Antibiotics and Calcium-Channel Blockers in Haemodialysis Patients: A Retrospective Chart Review"],"prefix":"10.1007","volume":"36","author":[{"given":"Swapnil","family":"Hiremath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shankar Prasad","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan B.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,20]]},"reference":[{"key":"88_CR1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1345\/aph.19138","volume":"34","author":"MP Pai","year":"2000","unstructured":"Pai MP, Graci DM, Amsden GW. Macrolide drug interactions: an update. Ann Pharmacother. 2000;34:495\u2013513.","journal-title":"Ann Pharmacother"},{"key":"88_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0009-9236(96)90163-0","volume":"60","author":"DG Bailey","year":"1996","unstructured":"Bailey DG, Bend JR, Arnold JM, Tran LT, Spence JD. Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Clin Pharmacol Ther. 1996;60:25\u201333.","journal-title":"Clin Pharmacol Ther"},{"key":"88_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1503\/cmaj.100702","volume":"183","author":"AJ Wright","year":"2011","unstructured":"Wright AJ, Gomes T, Mamdani MM, Horn JR, Juurlink DN. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. CMAJ. 2011;183:303\u20137.","journal-title":"CMAJ"},{"key":"88_CR4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.2000.00261.x","volume":"50","author":"JF Westphal","year":"2000","unstructured":"Westphal JF. Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin. Br J Clin Pharmacol. 2000;50:285\u201395.","journal-title":"Br J Clin Pharmacol"},{"key":"88_CR5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2146\/ajhp110486","volume":"69","author":"A Henneman","year":"2012","unstructured":"Henneman A, Thornby KA. Risk of hypotension with concomitant use of calcium-channel blockers and macrolide antibiotics. Am J Health Syst Pharm. 2012;69:1038\u201343.","journal-title":"Am J Health Syst Pharm"},{"key":"88_CR6","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ajh.2008.269","volume":"21","author":"NH McInnis","year":"2008","unstructured":"McInnis NH, Fodor G, Lum-Kwong MM, Leenen FH. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP). Am J Hypertens. 2008;21:1210\u20135.","journal-title":"Am J Hypertens"},{"key":"88_CR7","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/j.ajkd.2003.08.028","volume":"42","author":"TF Griffith","year":"2003","unstructured":"Griffith TF, Chua BS, Allen AS, Klassen PS, Reddan DN, Szczech LA. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2003;42:1260\u20139.","journal-title":"Am J Kidney Dis"},{"key":"88_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000345484","volume":"35","author":"S Thijssen","year":"2013","unstructured":"Thijssen S, Kappel F, Kotanko P. Absolute blood volume in hemodialysis patients: why is it relevant, and how to measure it? Blood Purif. 2013;35:63\u201371.","journal-title":"Blood Purif"},{"key":"88_CR9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1681\/ASN.2006040406","volume":"18","author":"BM Chavers","year":"2007","unstructured":"Chavers BM, Solid CA, Gilbertson DT, Collins AJ. Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol. 2007;18:952\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"88_CR10","doi-asserted-by":"crossref","unstructured":"K\/DOQI Working Group. K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005; 45:S1\u2013153.","DOI":"10.1053\/j.ajkd.2005.01.019"},{"key":"88_CR11","doi-asserted-by":"crossref","unstructured":"Kooman J, Basci A, Pizzarelli F, Canaud B, Haage P, Fouque D, Konner K, Martin-Malo A, Pedrini L, Tattersall J, Tordoir J, Vennegoor M, Wanner C, ter Wee P, Vanholder R. EBPG guideline on haemodynamic instability. Nephrol Dial Transplant. 2007; 22 Suppl 2:ii22\u201344.","DOI":"10.1093\/ndt\/gfm019"},{"issue":"Suppl 6","key":"88_CR12","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1097\/00005344-198812006-00024","volume":"12","author":"F Follath","year":"1988","unstructured":"Follath F, Taeschner W. Clinical pharmacology of calcium antagonists. J Cardiovasc Pharmacol. 1988;12(Suppl 6):S98\u2013100.","journal-title":"J Cardiovasc Pharmacol"},{"key":"88_CR13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2165\/00003088-198611040-00004","volume":"11","author":"CH Kleinbloesem","year":"1986","unstructured":"Kleinbloesem CH, van Brummelen P, Woittiez AJ, Faber H, Breimer DD. Influence of haemodialysis on the pharmacokinetics and haemodynamic effects of nifedipine during continuous intravenous infusion. Clin Pharmacokinet. 1986;11:316\u201322.","journal-title":"Clin Pharmacokinet"},{"key":"88_CR14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2362.2011.02579.x","volume":"42","author":"M Schmidt","year":"2012","unstructured":"Schmidt M, Johansen MB, Robertson DJ, Maeng M, Kaltoft A, Jensen LO, Tilsted HH, Botker HE, Sorensen HT, Baron JA. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events. Eur J Clin Invest. 2012;42:266\u201374.","journal-title":"Eur J Clin Invest"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0088-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-013-0088-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0088-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T18:43:13Z","timestamp":1563475393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-013-0088-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,20]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1007\/s40264-013-0088-9","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,20]]}}}